Trademark: 90521074
Status Date
Monday, July 18, 2022
Filing Date
Tuesday, February 9, 2021
Published for Opposition
Tuesday, October 19, 2021
Abandoned Date
Monday, July 18, 2022
35 providing consumer product and pricing information about the goods of others in the field of pharmaceuticals, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
42 providing a website featuring technology that allows users to access pharmaceuticals; providing a website featuring online nondownloadable software for use in connection with the collection, analysis, and sharing of personal medical data; providing a website featuring online nondownloadable software for use in obtaining information about and purchasing prescription drugs and over the counter medications; providing a website featuring online nondownloadable software for use in obtaining prescription and over the counter medications and referrals to healthcare providers and pharmacy services
Jul 18, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 18, 2022
Abandonment - No Use Statement Filed
Dec 14, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2021
Published For Opposition
Sep 29, 2021
Notification Of Notice Of Publication E-Mailed
Sep 13, 2021
Approved For Pub - Principal Register
Sep 9, 2021
Teas/Email Correspondence Entered
Sep 8, 2021
Correspondence Received In Law Office
Sep 8, 2021
Teas Response To Office Action Received
Sep 8, 2021
Teas Change Of Correspondence Received
Sep 8, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 8, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 8, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 7, 2021
Notification Of Examiner's Amendment/Priority Action E-Mailed
Sep 7, 2021
Examiner's Amendment/Priority Action E-Mailed
Sep 7, 2021
Combined Examiner's Amendment/Priority Action Automatic Entry
Sep 7, 2021
Examiners Amendment And/Or Priority Action - Completed
Sep 2, 2021
Assigned To Examiner
May 14, 2021
New Application Office Supplied Data Entered In Tram
Feb 12, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
